Medicine and Dentistry
Abdominal Radiology
9%
Biological Marker
8%
Biopsy Technique
24%
Cholangiocarcinoma
12%
Computer Assisted Tomography
9%
Conservative Treatment
5%
Contrast Medium
6%
Defecography
6%
Diagnosis
7%
Diagnostic Performance
14%
Diffusion MRI
21%
Disease
11%
Dynamic Contrast-Enhanced MRI
6%
Fibrosis
11%
Gadoxetic Acid
18%
Gleason Score
9%
Hepatocellular Carcinoma
75%
Image Quality
7%
Kidney Allograft
5%
Liver Cirrhosis
11%
Logistic Regression Analysis
6%
Magnetic Resonance Elastography
8%
Magnetic Resonance Imaging
100%
Magnetic Resonance Imaging
6%
Malignant Neoplasm
6%
Multiparametric Magnetic Resonance Imaging
32%
Neoplasm
41%
Odds Ratio
5%
Portal Hypertension
6%
Prostate Biopsy
5%
Prostate Cancer
42%
Prostate Specific Antigen
10%
Prostatectomy
9%
Radioembolization
6%
Radiomics
17%
Reproducibility
5%
Treatment Response
10%
Yttrium 90
10%
Keyphrases
4Kscore
6%
Advanced Fibrosis
5%
Adverse Pathology
5%
Apparent Diffusion Coefficient
11%
Area under the Curve
6%
Chronic Liver Disease
5%
Clinically Significant Prostate Cancer
8%
Data Systems
19%
Diagnostic Performance
15%
Diffusion-weighted
5%
Diffusion-weighted Imaging
17%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
7%
Fibrosis
6%
Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)
12%
Gadoxetic Acid-enhanced MRI
5%
Gleason Grade Group
7%
Hepatic Steatosis
8%
Hepatobiliary Phase
7%
Hepatocellular Carcinoma
63%
Hepatocellular Carcinoma Surveillance
13%
Intrahepatic Cholangiocarcinoma (iCCA)
9%
Liver
12%
Liver Imaging
9%
Liver Transplantation
6%
Magnetic Resonance
5%
Magnetic Resonance Imaging
30%
Magnetic Resonance Imaging Features
5%
MRI Radiomics
7%
Multi-institutional Study
6%
Multiparametric MRI (mpMRI)
42%
Nomogram
10%
Non-invasive Imaging
7%
Odds Ratio
5%
Positive Predictive Value
5%
Prostate
7%
Prostate Cancer
19%
Prostate Imaging Reporting
10%
Prostate-specific Antigen Density
6%
Radiologists
7%
Radiomics
17%
Reporting System
19%
Response Criteria
6%
Society of Abdominal Radiology
5%
T1 Mapping
6%
T1-weighted Imaging
10%
T2-weighted Imaging (T2WI)
5%
Treatment Response
5%
Tumor
11%
Ultrasound
9%
Yttrium-90 Radioembolization
6%